| Literature DB >> 28584257 |
Jinglei Yang1,2, Peter S Reinach1,2, Sen Zhang1,2, Miaozhen Pan1,2, Wenfeng Sun1,2, Bo Liu1,2, Fen Li1,2, Xiaoqing Li1,2, Aihua Zhao3, Tianlu Chen3, Wei Jia3, Jia Qu4,5, Xiangtian Zhou6,7.
Abstract
Retinal metabolic changes have been suggested to be associated with myopia development. However, little is known about either their identity or time dependent behavior during this sight compromising process. To address these questions, gas chromatography time-of-flight mass spectrometry (GC-TOF/MS) was applied to compare guinea pig retinal metabolite levels in form deprivation (FD) eyes at 3 days and 2 weeks post FD with normal control (NC) eyes. Orthogonal partial least squares (OPLS) models discriminated between time dependent retinal metabolic profiles in the presence and absence of FD. Myopia severity was associated with more metabolic pattern differences in the FD than in the NC eyes. After 3 days of FD, 11 metabolite levels changed and after 2 weeks the number of differences increased to 16. Five metabolites continuously decreased during two weeks of FD. Two-way ANOVA of the changes identified by OPLS indicates that 15 out of the 22 metabolites differences were significant. Taken together, these results suggest that myopia progression is associated with an inverse relationship between increases in glucose accumulation and lipid level decreases in form-deprived guinea pig eyes. Such changes indicate that metabolomic studies are an informative approach to identify time dependent retinal metabolic alterations associated with this disease.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28584257 PMCID: PMC5459838 DOI: 10.1038/s41598-017-03075-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Group assignment paradigm. Guinea pigs were randomly assigned to FD groups and NC groups at an age of 14 days. Animals in the FD groups were monocularly deprived, whereas those in the NC groups did not receive any treatment. A filled circle indicates an FD eye, and an open circle indicates an unpatched F eye. Twenty-four animals in the FD and 10 in NC groups were sacrificed 3 days later (i.e., 17 days of age), and the eyes were designated as FD3d and NC3d, respectively. Two FD eyes from 2 animals in the FD3d group were pooled together and designated as FD3d-T, and the two F eyes were pooled and named FD3d-F. Twenty-four animals in the FD and 12 in NC group were sacrificed at the age of 28 days and designated as NC2w and FD2w. Two FD eyes from 2 animals in the FD2w group were pooled together and designated as FD2w-T, and the two F eyes were pooled and designated as FD2w-F.
Figure 2FD induced axial myopia after 2 weeks. Panels (A), C and E show refraction, vitreous chamber depth and axial length of animals in NC3d and FD3d at age of 14 and 17 days, and those of animals in NC2w and FD2w at age of 14 and 28 days. Panels (B,D and F) show differences in refraction, vitreous chamber depth and axial length before and after 3 days of FD for animals in NC3d and FD3d, and differences before and after 14 days of FD for animals in NC2w and FD2w. Sample number: 10 in NC3d, 24 in FD3d, 12 in NC2w, 24 in FD2w. Data are shown as mean ± standard error of the mean(SE). The asterisk in (A,C and E) signifies a significant difference between right and left eyes within a group (p < 0.05). Hashtag symbol in (B,D and F) designates a significant difference between FD group and respective control group (#p < 0.05; ##p < 0.01).
Figure 3FD induced retinal metabolic profile shifts. Based on the content of 101 identified retinal metabolites, metabolome changes induced by 3 days and 2 weeks of FD were different from age-matched NC3d (A) and NC2w (B) using OPLS models. Samples from FD3d-T localized between FD2w-T and NC2w in the t predicted plot using NC3d and FD3d-T as a prediction set of the OPLS model discriminating FD2w-T and NC2w (C), which indicates an association between FDM development and metabolic profile changes. t[1]P: score calculated with predictive components; t[2]O: score calculated with orthogonal components. tPS[1]P: score calculated with predictive components of samples in prediction set (PS); tPS[2]O: score calculated with orthogonal components of samples in PS.
Differential metabolite profiles during myopia development.
| Compound | FD3d versus NC3d | FD2w versus NC2w | p value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| FC | VIP | FC | VIP | ||||||
| T/C | T/F | T vs C | F VS T | T/C | T/F | T vs C | F VS T | T vs C | |
| Mannose | 2.69 | 0.50 |
|
| 1.95 | 1.26 | 0.70 | 0.49 | 0.060 |
| Urea | 0.69 | 0.85 |
|
| 0.86 | 1.00 |
| 0.00 |
|
| Glucose | 1.37 | 0.82 |
|
| 1.31 | 0.98 |
| 0.19 |
|
| Arabinose | 0.45 | 0.85 |
|
| 0.92 | 0.88 | 0.31 |
| 0.148 |
| Tyrosine | 0.86 | 0.72 |
|
| 0.91 | 0.87 | 0.52 |
| 0.096 |
| Glutamic acid | 0.90 | 0.85 |
|
| 0.91 | 0.99 | 0.82 | 0.12 | 0.112 |
|
| 0.79 | 0.78 |
|
| 0.86 | 0.87 | 0.95 |
|
|
|
| 0.87 | 0.80 |
|
| 0.85 | 0.83 |
|
|
|
|
| 0.85 | 0.78 |
|
| 0.81 | 0.81 |
|
|
|
|
| 0.85 | 0.93 |
| 0.62 | 0.78 | 0.88 |
|
|
|
|
| 0.94 | 0.84 |
|
| 0.87 | 0.85 |
|
|
|
| Arachidic acid (20:0) | 0.93 | 1.04 | 0.26 | 0.14 | 0.26 | 0.66 |
|
|
|
| Octadecenoic acid (18:1) | 0.96 | 0.93 | 0.45 | 0.52 | 0.73 | 0.94 |
|
|
|
| Octadecanoic acid (18:0) | 1.03 | 0.94 | 0.43 | 0.52 | 0.82 | 0.92 |
|
|
|
| Arachidonic acid (20:4) | 0.96 | 0.96 | 0.54 | 0.38 | 0.80 | 0.94 |
|
|
|
| Cholesterol | 0.98 | 0.93 | 0.43 | 0.67 | 0.80 | 0.92 |
|
|
|
| Ethanolamine | 1.08 | 0.95 | 0.38 | 0.29 | 0.79 | 0.85 |
|
| 0.179 |
| Hexadecanoic acid (16:0) | 1.04 | 0.90 | 0.66 | 0.79 | 0.80 | 0.93 |
|
|
|
| Tetradecanoic acid (14:0) | 0.91 | 0.93 | 0.90 | 0.57 | 0.71 | 0.87 |
|
|
|
| Octadecadienoic acid (18:2) | 0.90 | 0.90 | 0.57 | 0.52 | 0.66 | 1.19 |
|
|
|
| 2-Ketoglutaric acid | 1.51 | 0.69 | 0.84 |
| 2.61 | 0.68 |
|
| 0.047 |
| GABA | 0.98 | 0.89 | 0.33 |
| 0.87 | 0.93 |
|
| 0.090 |
FC: fold change, abundance of individual metabolites in the former versus the latter group. T: FD eyes; F: fellow eyes; C: normal control eyes. VIP: variable importance in the OPLS model discriminating two groups. P values are from two-way ANOVA assessing main effect of treatment type (with or without FD), adjusted by FDR method with q value set at 0.05. Compound changes with VIP > 1.0 and P < 0.05(shown in italic bold) were regarded as significant. The five listed boldface compounds were significantly different in both FD3d versus NC3d and FD2w versus NC2w. Except for them, the first 6 compounds in the table were significantly different in FD3d versus NC3d and the bottom 11were significantly different in FD2w versus NC2w.